Sera
BIOHIPPO InVivoMAb Anti-Human GIPR/GIP-R Antibody (Iv0211), 100 µg
GIPR/GIP-R Recombinant Antibody (clone Iv0211) is a recombinant Human IgG1, kappa antibody specific for GIPR/GIP-R. It reacts with Human. Suitable for ELISA, FuncS. Recombinant production ensures high specificity and lot-to-lot reproducibility. Supplied as 100 ug.
Bioss KD-Validated Complement C3 Rab
Complement C3 Primary Antibody Unconjugated Public Immunogen Range 850-900/1663 Host Species Rabbit Target Species Human Clonality Monoclonal Applications WB IC Concentration Lot dependent Size 50 ul Storage Buffer Supplied in PBS (pH 7 4) containing 50% glycerol and 0 02% sodium azide
Cayman Chemical SInIgrInhydrate 100mg
A glucosinolate; inhibits NLRP3 inflammasome activation in ATP-stimulated, LPS-primed RAW 264.7 cells in a concentration-dependent manner; reduces LPS-induced NO and PGE2 production, as well as NF-κB activation, in RAW 264.7 cells; induces cell cycle arrest at the G0/G1 phase in HepG2 hepatocellular carcinoma cells at 0.1 and 0.5 mM; increases in renal glomerular basement membrane thickness, as well as increases in systolic and diastolic blood pressure, in a rat model of angiotensin II-induced hypertension
Cayman Chemical DehydroascorbIc AcId 100mg
An oxidized form of ascorbic acid; inhibits hydrogen peroxide-induced cell death in murine astrocytes by approximately 74 and 83% at 0.5 and 1 mM, respectively; increases GPX and glutathione reductase activity and inhibits ROS production in hydrogen peroxide-treated astrocytes at 1 mM; increases cerebral blood flow and reduces infarct volume and mortality in a mouse model of cerebral ischemia-reperfusion injury induced by transient MCAO when administered prior to ischemia at 40 and 250 mg/kg; reduces infarct volume in a permanent MCAO mouse model when administered pre- or post-ischemia at 250 and 500 mg/kg, respectively